Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2009-06-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ondansetron-Dexa group
Use 2 different antiemetics
Ondansetron, Dexamethasone
Use of ondansetron and dexamethasone as combined antiemetics
Midazolam, Dexa group
use of midazolam and dexamethasone
Midazolam, dexamethasone
use of midazolam and dexamethasone as combined antiemetic
Placebo
Saline will be given
Placebo
Saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Saline
Ondansetron, Dexamethasone
Use of ondansetron and dexamethasone as combined antiemetics
Midazolam, dexamethasone
use of midazolam and dexamethasone as combined antiemetic
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* children who have taken anti-emetic medications, antihistaminics, steroids, or psychoactive drugs within 24 hours before surgery
4 Years
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Khaled Eye Specialist Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Waleed Riad, MD, AB, SB
Role: PRINCIPAL_INVESTIGATOR
King Khaled Eye Specialist Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
king Khaled Eye Specialist hospital
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Riad W, Altaf R, Abdulla A, Oudan H. Effect of midazolam, dexamethasone and their combination on the prevention of nausea and vomiting following strabismus repair in children. Eur J Anaesthesiol. 2007 Aug;24(8):697-701. doi: 10.1017/S0265021507000166. Epub 2007 Apr 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RP 0917
Identifier Type: -
Identifier Source: org_study_id